Identification of a transactivation motif in the CLN3 protein

被引:0
|
作者
Leung, KY [1 ]
Greene, NDE [1 ]
Munroe, PB [1 ]
Mole, SE [1 ]
机构
[1] UCL Royal Free & UCL Med Sch, Rayne Inst, Dept Paediat, London WC1E 6JJ, England
关键词
CLN3; activation domain; transcription factor; yeast-one-hybrid;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A transactivation motif has been identified in the neurodegenerative disease protein, CLN3. The C-terminal domain (residues 394-438) of CLN3 can function as a transcriptional activator when fused to the DNA binding domain, LexA. A series of deletion and substitution constructs have been generated to identify the essential region for transactivation. A similar motif is also present in the POU domain transcription factor, nubbin. However, this domain alone does not activate transcription, allowing further localisation of the critical residues in CLN3 required for activity.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 50 条
  • [1] Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein
    Mitchison, HM
    Taschner, PEM
    Kremmidiotis, G
    Callen, DF
    Doggett, NA
    Lerner, TJ
    Janes, RB
    Wallace, BA
    Munroe, PB
    ORawe, AM
    Gardiner, RM
    Mole, SE
    NEUROPEDIATRICS, 1997, 28 (01) : 12 - 14
  • [2] Expression studies of CLN3 protein
    Kaczmarski, W
    Kida, E
    Lach, A
    Rubenstein, R
    Zhong, N
    Wisniewski, KE
    NEUROPEDIATRICS, 1997, 28 (01) : 33 - 36
  • [3] Immunochemical studies of the CLN3 protein
    Wisniewski, KE
    Kida, E
    Kaczmarski, W
    Deshmukh, D
    Mehta, P
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (05): : 96 - 96
  • [4] Identification of Modifier Genes of CLN3 Disease
    Lebrun, Anne-Helene
    Khosrawi, Parisa
    Storch, Stephan
    Pohl, Sandra
    Kilian, Dirk
    Streichert, Thomas
    Kohlschuetter, Alfried
    Ullrich, Kurt
    Braulke, Thomas
    Schulz, Angela
    EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (03) : 391 - 391
  • [5] Farnesylation of Batten disease CLN3 protein
    Pullarkat, RK
    Morris, GN
    NEUROPEDIATRICS, 1997, 28 (01) : 42 - 44
  • [6] Studies of membrane association of CLN3 protein
    Kaczmarski, W
    Wisniewski, KE
    Golabek, A
    Kaczmarski, A
    Kida, E
    Michalewski, M
    MOLECULAR GENETICS AND METABOLISM, 1999, 66 (04) : 261 - 264
  • [7] Intracellular trafficking of the JNCL protein CLN3
    Haskell, RE
    Derksen, TA
    Davidson, BL
    MOLECULAR GENETICS AND METABOLISM, 1999, 66 (04) : 253 - 260
  • [8] IDENTIFICATION OF POTENTIAL BIOMARKERS AND MODIFIERS OF CLN3 DISEASE
    Lebrun, A. H.
    Moll-Kosrawi, P.
    Storch, S.
    Pohl, S.
    Kilian, D.
    Streichert, T.
    Mole, S. E.
    Ullrich, K.
    Kohlschutter, A.
    Braulke, T.
    Schulz, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S140 - S140
  • [9] Nature of Batten disease CLN3 protein in brain
    Pullarkat, RK
    Pullarkat, PS
    Morris, GN
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S193 - S193
  • [10] The CLN3 gene and protein: What we know
    Mirza, Myriam
    Vainshtein, Anna
    DiRonza, Alberto
    Chandrachud, Uma
    Haslett, Luke J.
    Palmieri, Michela
    Storch, Stephan
    Groh, Janos
    Dobzinski, Niv
    Napolitano, Gennaro
    Schmidtke, Carolin
    Kerkovich, Danielle, I
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (12):